nodes	percent_of_prediction	percent_of_DWPC	metapath
Rescinnamine—ACE—hindlimb—leprosy	0.0969	0.171	CbGeAlD
Rescinnamine—ACE—arm—leprosy	0.0926	0.163	CbGeAlD
Rescinnamine—ACE—appendage—leprosy	0.0831	0.146	CbGeAlD
Rescinnamine—ACE—peripheral nervous system—leprosy	0.0756	0.133	CbGeAlD
Rescinnamine—ACE—nerve—leprosy	0.0589	0.104	CbGeAlD
Rescinnamine—ACE—blood vessel—leprosy	0.0463	0.0815	CbGeAlD
Rescinnamine—ACE—eye—leprosy	0.0246	0.0434	CbGeAlD
Rescinnamine—SLC18A2—tendon—leprosy	0.0239	0.0421	CbGeAlD
Rescinnamine—SLC18A2—testis—leprosy	0.0198	0.0348	CbGeAlD
Rescinnamine—Psoriasis—Thalidomide—leprosy	0.0196	0.0454	CcSEcCtD
Rescinnamine—SLC18A2—nervous system—leprosy	0.0194	0.0342	CbGeAlD
Rescinnamine—Hypothyroidism—Thalidomide—leprosy	0.0192	0.0445	CcSEcCtD
Rescinnamine—Tooth disorder—Thalidomide—leprosy	0.019	0.044	CcSEcCtD
Rescinnamine—Seborrhoeic dermatitis—Thalidomide—leprosy	0.0181	0.0419	CcSEcCtD
Rescinnamine—Tingling sensation—Thalidomide—leprosy	0.0153	0.0355	CcSEcCtD
Rescinnamine—Influenza—Dapsone—leprosy	0.0151	0.035	CcSEcCtD
Rescinnamine—Endocrine disorder—Thalidomide—leprosy	0.0149	0.0344	CcSEcCtD
Rescinnamine—Accidental injury—Thalidomide—leprosy	0.0139	0.0323	CcSEcCtD
Rescinnamine—Photosensitivity reaction—Dapsone—leprosy	0.0138	0.0319	CcSEcCtD
Rescinnamine—Skin discolouration—Thalidomide—leprosy	0.0137	0.0316	CcSEcCtD
Rescinnamine—ACE—testis—leprosy	0.0135	0.0238	CbGeAlD
Rescinnamine—ACE—nervous system—leprosy	0.0133	0.0233	CbGeAlD
Rescinnamine—Sinusitis—Dapsone—leprosy	0.0126	0.0293	CcSEcCtD
Rescinnamine—Pharyngitis—Dapsone—leprosy	0.012	0.0278	CcSEcCtD
Rescinnamine—Hypertonia—Thalidomide—leprosy	0.0108	0.025	CcSEcCtD
Rescinnamine—Erythema—Dapsone—leprosy	0.0105	0.0244	CcSEcCtD
Rescinnamine—Injury—Thalidomide—leprosy	0.00974	0.0225	CcSEcCtD
Rescinnamine—Dermatitis bullous—Thalidomide—leprosy	0.00937	0.0217	CcSEcCtD
Rescinnamine—Cough—Dapsone—leprosy	0.00919	0.0213	CcSEcCtD
Rescinnamine—Insomnia—Dapsone—leprosy	0.00777	0.018	CcSEcCtD
Rescinnamine—Influenza—Thalidomide—leprosy	0.00774	0.0179	CcSEcCtD
Rescinnamine—Angina pectoris—Thalidomide—leprosy	0.00754	0.0174	CcSEcCtD
Rescinnamine—Bronchitis—Thalidomide—leprosy	0.00744	0.0172	CcSEcCtD
Rescinnamine—Photosensitivity reaction—Thalidomide—leprosy	0.00706	0.0163	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Dapsone—leprosy	0.00703	0.0163	CcSEcCtD
Rescinnamine—Acute coronary syndrome—Thalidomide—leprosy	0.0068	0.0157	CcSEcCtD
Rescinnamine—Abdominal pain—Dapsone—leprosy	0.00679	0.0157	CcSEcCtD
Rescinnamine—Myocardial infarction—Thalidomide—leprosy	0.00676	0.0157	CcSEcCtD
Rescinnamine—Conjunctivitis—Thalidomide—leprosy	0.00671	0.0155	CcSEcCtD
Rescinnamine—Sinusitis—Thalidomide—leprosy	0.00647	0.015	CcSEcCtD
Rescinnamine—Rhinitis—Thalidomide—leprosy	0.00621	0.0144	CcSEcCtD
Rescinnamine—Hypoaesthesia—Thalidomide—leprosy	0.00616	0.0143	CcSEcCtD
Rescinnamine—Pharyngitis—Thalidomide—leprosy	0.00615	0.0142	CcSEcCtD
Rescinnamine—Headache—Dapsone—leprosy	0.00538	0.0125	CcSEcCtD
Rescinnamine—Dysgeusia—Thalidomide—leprosy	0.00528	0.0122	CcSEcCtD
Rescinnamine—Back pain—Thalidomide—leprosy	0.00521	0.0121	CcSEcCtD
Rescinnamine—Nausea—Dapsone—leprosy	0.0051	0.0118	CcSEcCtD
Rescinnamine—Cough—Thalidomide—leprosy	0.0047	0.0109	CcSEcCtD
Rescinnamine—Hypertension—Thalidomide—leprosy	0.00465	0.0108	CcSEcCtD
Rescinnamine—Myalgia—Thalidomide—leprosy	0.00459	0.0106	CcSEcCtD
Rescinnamine—Discomfort—Thalidomide—leprosy	0.00453	0.0105	CcSEcCtD
Rescinnamine—Oedema—Thalidomide—leprosy	0.0044	0.0102	CcSEcCtD
Rescinnamine—Infection—Thalidomide—leprosy	0.00437	0.0101	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Thalidomide—leprosy	0.00401	0.00928	CcSEcCtD
Rescinnamine—Insomnia—Thalidomide—leprosy	0.00398	0.00921	CcSEcCtD
Rescinnamine—Paraesthesia—Thalidomide—leprosy	0.00395	0.00914	CcSEcCtD
Rescinnamine—Pain—Thalidomide—leprosy	0.00376	0.00871	CcSEcCtD
Rescinnamine—Constipation—Thalidomide—leprosy	0.00376	0.00871	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Thalidomide—leprosy	0.0036	0.00833	CcSEcCtD
Rescinnamine—Urticaria—Thalidomide—leprosy	0.0035	0.00809	CcSEcCtD
Rescinnamine—Abdominal pain—Thalidomide—leprosy	0.00348	0.00805	CcSEcCtD
Rescinnamine—Hypersensitivity—Thalidomide—leprosy	0.00324	0.0075	CcSEcCtD
Rescinnamine—Pruritus—Thalidomide—leprosy	0.00311	0.0072	CcSEcCtD
Rescinnamine—Dizziness—Thalidomide—leprosy	0.00291	0.00673	CcSEcCtD
Rescinnamine—Rash—Thalidomide—leprosy	0.00277	0.00642	CcSEcCtD
Rescinnamine—Dermatitis—Thalidomide—leprosy	0.00277	0.00641	CcSEcCtD
Rescinnamine—Headache—Thalidomide—leprosy	0.00276	0.00638	CcSEcCtD
Rescinnamine—Nausea—Thalidomide—leprosy	0.00261	0.00605	CcSEcCtD
